Internal Medicine, Medical Oncology · Glendale, CA
NPI
1568537314
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
1505 Wilson Ter, Suite 340
Glendale, CA, 91206
Phone (818) 543-7574
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
2,734 services
Medicare patients, 2024
257
Average age 74
Drug cost, 2024
$4.0M
1,451 prescriptions
Company payments, 2025
$6,171
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymundo Romero was code 99232 (hospital e&m - subsequent), 1,857 times for 113 patients. In total Raymundo Romero billed 2,734 services in 19 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,857 | 113 | $70.19 | $130K |
| 99213 Office E&M - Established | Office | 316 | 123 | $73.05 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 74 | $14.45 | $1,691 |
| 99231 Hospital E&M - Subsequent | Facility | 83 | 18 | $43.94 | $3,647 |
| 99223 Hospital E&M - Initial | Facility | 71 | 66 | $154.16 | $11K |
| 99214 Office E&M - Established | Office | 67 | 44 | $109.84 | $7,359 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 48 | $105.68 | $5,918 |
| 99204 Office E&M - New | Office | 25 | 25 | $141.97 | $3,549 |
By year: 2022 $170K for 2,471 services; 2023 $164K for 2,683 services; 2024 $187K for 2,734 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raymundo Romero prescribed most often to Medicare patients was Anastrozole, with 221 prescriptions and refills. In total Raymundo Romero wrote 1,451 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 221 | 395 | 47 | $2,402 |
| Hydroxyurea Generic | 84 | 143 | 16 | $2,273 |
| Lupron Depot Leuprolide Acetate | 69 | 77 | 11 | $149K |
| Alendronate Sodium Generic | 69 | 106 | 12 | $252 |
| Xgeva Denosumab | 63 | 63 | Under 11 | $190K |
| Zolpidem Tartrate Generic | 47 | 47 | Under 11 | $77.14 |
| Eliquis Apixaban | 43 | 43 | Under 11 | $25K |
| Pantoprazole Sodium Generic | 42 | 60 | 13 | $179 |
| Procrit Epoetin Alfa | 42 | 42 | Under 11 | $68K |
| Dexamethasone Generic | 35 | 40 | Under 11 | $765 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 33 | 33 | 15 | $621 |
| Abiraterone Acetate Generic | 32 | 32 | Under 11 | $98K |
| Prednisone Generic | 32 | 32 | Under 11 | $78.26 |
| Exemestane Generic | 30 | 54 | Under 11 | $6,938 |
| Gabapentin Generic | 29 | 40 | 12 | $621 |
Brand drugs: - claims; generic drugs: 971 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymundo Romero $6,171 ($6,171 in general payments such as food, travel and fees) from 46 companies. The largest payer was Janssen Biotech, Inc. with $902.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 28 | $902 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $461 |
| Pfizer Inc. PFE | 20 | $375 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $362 |
| Celgene Corporation BMY | 18 | $355 |
| Merck Sharp & Dohme LLC MRK | 12 | $301 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $275 |
| Incyte Corporation INCY | 9 | $223 |
| GlaxoSmithKline, LLC. GSK | 9 | $192 |
| Daiichi Sankyo Inc. 4568.T | 12 | $182 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.